article Open Access
Role of biomarkers in the diagnosis of myxomatous mitral valve disease in canines
International Journal of Veterinary Sciences and Animal Husbandry · 2025 · Vol. 10(9) · pp. 334–337
Abstract
This study focuses on identifying the occult stage of Myxomatous Mitral Valve Degeneration (MMVD) in dogs through the use of cardiac biomarkers. Serum NT-proBNP levels were found to be significantly higher in MMVD than in the healthy control group, suggesting an enlargement of the heart.
Cardiovascular Conditions and TreatmentsCardiac tumors and thrombiVirus-based gene therapy researchDiseaseMitral valveOccultDegeneration (medical)Stage (stratigraphy)
Citations
0
FWCI
0.00
field-weighted impact
References
0
Percentile
40%
vs. same field & year
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.